Search This Blog

Monday, August 3, 2026

Craig-Hallum upgrades CareDx to Buy from Hold and raises price target to $64 from $35

 


  • Craig-Hallum describes CareDx’s recently raised 2026 revenue guidance as conservative, supporting its rating upgrade and higher price target.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.